Separation of the ADC Brentuximab vedotin from its aggregates and fragments
contributed by YMC |
Drug-to-antibody ratios (DAR) of antibody-drug-conjugates (ADCs) are important for their therapeutic efficacy and pharmacokinetics. Typically, the DAR of 2nd generation ADC such as Brentuximab vedotin (Adcetris®) is determined by hydrophobic interaction chromatography (HIC).
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!